AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Enoxaparin (Systemic).(Drug overview)

USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language

| May 01, 2006 | COPYRIGHT 1996 USP DIĀ® and Advice for the PatientĀ® are registered trademarks of USP used under license to Micromedex, Inc. (Hide copyright information)Copyright
 
In the U.S. -- 
     Lovenox 
 
In Canada -- 
     Lovenox 
     Antithrombotic 
Description 

Enoxaparin ( e-nox-a-PA-rin) is used to prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. This medicine is used for several days after hip or knee replacement surgery, and in some cases following abdominal surgery, while you are unable to walk. It is during this time that blood clots are most likely to form. Enoxaparin is also used if you are unable to get out of bed because of a serious illness. In addition, enoxaparin is used to prevent blood clots from forming in the arteries of the heart during certain types of chest pain and heart attacks. Enoxaparin also may be used for other conditions as determined by your doctor.

Enoxaparin is available only with your doctor's prescription, in the following dosage form:

 
Parenteral 
 
     Injection (U.S. and Canada) 
Before Using This Medicine 

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For enoxaparin, the following should be considered:

 
Allergies -- 

Tell your doctor if you have ever had any unusual or allergic reaction to enoxaparin or to heparin. Also tell your health care professional if you are allergic to any other substances, such as foods, especially pork or pork products, preservatives, or dyes.

 
Pregnancy -- 

Enoxaparin has not had adequate studies performed in pregnant women. However, if you are pregnant your doctor will need to closely monitor you because of an increased risk of bleeding. In pregnant women who have an artificial heart valve, …

Related articles from newspapers, magazines, journals, and more
EXCLAIM study publication in Annals of Internal Medicine shows that extended...
News wire article from: Chemical Business Newsbase July 6, 2010 700+ words
The New England Journal of Medicine publishes the STEEPLE study which...
News wire article from: Chemical Business Newsbase September 7, 2006 700+ words
Experience with enoxaparin in patients with mechanical heart valves who must...
Magazine article from: Heart Ferreira, I. Dos, L. Tornos, P. Nicolau, I. Permanyer-Miralda, G. Soler-Soler, J. May 1, 2003 700+ words
Enoxaparin (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language February 1, 2006 700+ words
Enoxaparin contamination: batches recalled.(Regulatory Action and News)
Magazine article from: WHO Drug Information March 22, 2008 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily